In SummaryPfizer has asked for emergency authorization to approve a COVID-19 vaccine for kids aged 5-11. If approved, shots could be distributed within a matter of weeks.
For kids who are living under the threat of the deadly Coronavirus, there is some hopeful news. Pfizer and BioNTech have asked the United States government to permit the use of its COVID-19 vaccine for children ages 5 to 11, according to the Associated Press.
If approved, the shots could be distributed within a matter of weeks. This news is significant as many parents and doctors have been pushing for emergency authorization so kids won’t be seriously ill with COVID-19.
According to the Associated Press, the next step is for the Food and Drug Administration to make a decision on if there is proof the vaccine will help younger kids, as it currently works for those aged 12 and up.
Before the news, Pfizer and BioNTech did a Phase 2/3 trial on 2,268 participants, which were children aged 5 to 11. The results showed the vaccine was safe and revealed robust neutralizing antibody responses.
“We are pleased to be able to submit data to regulatory authorities for this group of school-aged children before the start of the winter season,” said CEO and co-founder of BioNTech Dr. Uğur Şahin. “The safety profile and immunogenicity data in children aged 5 to 11 years vaccinated at a lower dose are consistent with those we have observed with our vaccine in other older populations at a higher dose.”
The CDC will make a final decision on whether or not to recommend the vaccine for those children, according to the Associated Press.